Ghent University Academic Bibliography

Miscellaneous

Angiosarcoma mimicking rhinophyma

Niels Hilhorst (UGent) , Evelien Verhaeghe (UGent) and Lieve Brochez (UGent)

(2023) JAMA DERMATOLOGY. 159(1). p.95-95

Cutaneous manifestations, clinical characteristics, and prognosis of patients with systemic sclerosis sine scleroderma : data from the International EUSTAR Database

Alain Lescoat, Suiyuan Huang, Patricia E. Carreira, Elise Siegert, Jeska de Vries-Bouwstra, Jörg H. W. Distler, Vanessa Smith (UGent) , Francesco Del Galdo, Branimir Anic, Nemanja Damjanov, et al.

(2023) JAMA DERMATOLOGY. 159(8). p.837-847

Add to list

Journal Article
A1
open access

Mental health and psychosocial quality-of-life burden among patients with vitiligo : findings from the Global VALIANT study

Kristen Bibeau, Khaled Ezzedine, John E. Harris, Nanja van Geel (UGent) , Pearl Grimes, Davinder Parsad, Mukta Tulpule, Jackie Gardner, Yan Valle, Gaone Tlhong Matewa, et al.

(2023) JAMA DERMATOLOGY. 159(10). p.1124-1128

Add to list

International eDelphi study to reach consensus on the methotrexate dosing regimen in patients with psoriasis

Astrid M. van Huizen, Stef P. Menting, Rolland Gyulai, Lars Iversen, Gayle E. van der Kraaij, Maritza A. Middelkamp-Hup, Richard B. Warren, Phyllis I. Spuls, Adrián A. Schejtman, Alexander Egeberg, et al.

(2022) JAMA DERMATOLOGY. 158(5). p.561-572

Add to list

Patient-relevant outcomes in psoriasis : a systematic review

Niels Hilhorst (UGent) , Elfie Deprez (UGent) , Nele Pauwels (UGent) , Lynda Grine (UGent) , Jo Lambert (UGent) and Isabelle Hoorens (UGent)

(2022) JAMA DERMATOLOGY. 158(7). p.806-811

Add to list

Credibility and generalization of the minimally important difference concept in dermatology : a scoping review

Reinhart Speeckaert (UGent) , Arno Belpaire (UGent) , Sandrine Herbelet (UGent) , Jo Lambert (UGent) and Nanja van Geel (UGent)

(2022) JAMA DERMATOLOGY. 158(11). p.1304-1314

Add to list

Journal Article
A1
open access

A comparison of psoriasis severity in pediatric patients treated with methotrexate vs biologic agents

Inge M. G. J. Bronckers, Amy S. Paller, Dennis P. West, Irene Lara-Corrales, Megha M. Tollefson, Wynnis L. Tom, Marcia Hogeling, Leah Belazarian, Claus Zachariae, Emmanuel Mahé, et al.

(2020) JAMA DERMATOLOGY. 156(4). p.384-392

Add to list

Journal Article
A1
open access

Effect of risankizumab on patient-reported outcomes in moderate to severe psoriasis : the UltIMMa-1 and UltIMMa-2 randomized clinical trials

Matthias Augustin, Jo Lambert (UGent) , Carla Zema, Elizabeth H. Z. Thompson, Min Yang, Eric Q. Wu, Viviana Garcia-Horton, Ziqian Geng, Joaquin M. Valdes, Avani Joshi, et al.

(2020) JAMA DERMATOLOGY. 156(12). p.1344-1353

Add to list

Safety of systemic agents for the treatment of pediatric psoriasis

Inge MGJ Bronckers, Marieke MB Seyger, Dennis P West, Irene Lara-Corrales, Megha Tollefson, Wynnis L Tom, Marcia Hogeling, Leah Belazarian, Claus Zachariae, Emmanuel Mahé, et al.

(2017) JAMA DERMATOLOGY. 153(11). p.1147-1157

Add to list

Cost-effectiveness and budget effect analysis of a population-based skin cancer screening

Lore Pil (UGent) , Isabelle Hoorens (UGent) , Katrien Vossaert (UGent) , Vibeke Kruse (UGent) , Isabelle Tromme, Niko Speybroeck, Lieven Annemans (UGent) and Lieve Brochez (UGent)

(2017) JAMA DERMATOLOGY. 153(2). p.147-153

Academic Bibliography

Angiosarcoma mimicking rhinophyma

Cutaneous manifestations, clinical characteristics, and prognosis of patients with systemic sclerosis sine scleroderma : data from the International EUSTAR Database

Mental health and psychosocial quality-of-life burden among patients with vitiligo : findings from the Global VALIANT study

International eDelphi study to reach consensus on the methotrexate dosing regimen in patients with psoriasis

Patient-relevant outcomes in psoriasis : a systematic review

Credibility and generalization of the minimally important difference concept in dermatology : a scoping review

A comparison of psoriasis severity in pediatric patients treated with methotrexate vs biologic agents

Effect of risankizumab on patient-reported outcomes in moderate to severe psoriasis : the UltIMMa-1 and UltIMMa-2 randomized clinical trials

Safety of systemic agents for the treatment of pediatric psoriasis

Cost-effectiveness and budget effect analysis of a population-based skin cancer screening

Contents

Support

Contact